Sarasin & Partners’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-219,490
| Closed | -$20.3M | – | 83 |
|
|
2024
Q2 | $20.3M | Buy |
219,490
+3,104
| +1% | +$287K | 0.18% | 42 |
|
|
2024
Q1 | $20.7M | Sell |
216,386
-15,830
| -7% | -$1.51M | 0.2% | 43 |
|
|
2023
Q4 | $17.7M | Sell |
232,216
-39,987
| -15% | -$3.05M | 0.19% | 48 |
|
|
2023
Q3 | $18.9M | Buy |
272,203
+3,525
| +1% | +$244K | 0.24% | 45 |
|
|
2023
Q2 | $25.3M | Sell |
268,678
-241,585
| -47% | -$22.8M | 0.29% | 43 |
|
|
2023
Q1 | $52.3M | Buy |
510,263
+254,390
| +99% | +$26.1M | 0.28% | 57 |
|
|
2022
Q4 | $19.1M | Buy |
255,873
+2,799
| +1% | +$209K | 0.25% | 53 |
|
|
2022
Q3 | $20.9M | Sell |
253,074
-456
| -0.2% | -$37.7K | 0.29% | 51 |
|
|
2022
Q2 | $24.1M | Buy |
+253,530
| New | +$24.1M | 0.3% | 54 |
|
|
2022
Q1 | – | Sell |
-254,535
| Closed | -$33M | – | 91 |
|
|
2021
Q4 | $33M | Hold |
254,535
| – | – | 0.3% | 57 |
|
|
2021
Q3 | $28.8M | Hold |
254,535
| – | – | 0.29% | 58 |
|
|
2021
Q2 | $26.4M | Buy |
254,535
+52,386
| +26% | +$5.43M | 0.28% | 55 |
|
|
2021
Q1 | $16.9M | Hold |
202,149
| – | – | 0.2% | 60 |
|
|
2020
Q4 | $18.4M | Buy |
202,149
+38,676
| +24% | +$3.53M | 0.24% | 57 |
|
|
2020
Q3 | $13M | Buy |
163,473
+31,473
| +24% | +$2.51M | 0.19% | 62 |
|
|
2020
Q2 | $9.12M | Buy |
+132,000
| New | +$9.12M | 0.15% | 67 |
|
|
2020
Q1 | – | Sell |
-95,769
| Closed | -$7.45M | – | 112 |
|
|
2019
Q4 | $7.45M | Sell |
95,769
-261
| -0.3% | -$20.3K | 0.11% | 83 |
|
|
2019
Q3 | $7.04M | Buy |
96,030
+30,405
| +46% | +$2.23M | 0.12% | 82 |
|
|
2019
Q2 | $4.04M | Sell |
65,625
-765
| -1% | -$47.1K | 0.07% | 99 |
|
|
2019
Q1 | $4.23M | Hold |
66,390
| – | – | 0.08% | 89 |
|
|
2018
Q4 | $3.39M | Hold |
66,390
| – | – | 0.07% | 91 |
|
|
2018
Q3 | $3.85M | Buy |
+66,390
| New | +$3.85M | 0.07% | 95 |
|